Morphological characterization of microglial states in human brain

Exploratory Score: 0.800 Price: $0.50 Alzheimer's disease human brain tissue Status: proposed

What This Experiment Tests

Exploratory experiment designed to discover new patterns targeting N/A in human brain tissue. Primary outcome: morphological classification of microglial states

Description

This study characterizes the morphological states of microglia in human brain tissue, defining four distinct phenotypes: ramified, amoeboid, phagocytic, and dystrophic microglia. The research focuses on identifying morphological markers that distinguish between these states, with particular attention to dystrophic microglia found in aged human brains that are thought to represent senescent cells. The study examines how microglial morphology changes with age and disease states, providing a framework for understanding microglial dysfunction in neurodegeneration.

TARGET GENE
N/A
MODEL SYSTEM
human brain tissue
ESTIMATED COST
$0
TIMELINE
0 months
PATHWAY
microglial activation and senescence pathways
SOURCE
extracted_from_pmid_34571885
PRIMARY OUTCOME
morphological classification of microglial states

Scoring Dimensions

Info Gain 0.00 (25%) Feasibility 0.00 (20%) Hyp Coverage 0.00 (20%) Cost Effect. 0.00 (15%) Novelty 0.00 (10%) Ethical Safety 0.00 (10%) 0.800 composite

📖 Wiki Pages

MicrogliaentityTREM2 Variants in Alzheimer's DiseasediseaseSporadic vs Familial Alzheimer's Disease: ComprehediseasePSEN2 Mutations in Alzheimer's DiseasediseasePSEN1 Mutations in Alzheimer's DiseasediseaseProdromal Alzheimer's DiseasediseasePreclinical Alzheimer's DiseasediseaseNeurodegenerationdiseaseInvestment Landscape: Alzheimer's DiseasediseaseEarly-Onset Alzheimer's Disease (EOAD)diseaseDLB, Parkinson's Disease, and Alzheimer's Disease:diseaseAPP Mutations in Alzheimer's DiseasediseaseAlzheimer's Disease vs Parkinson's Disease ComparidiseaseAlzheimer's Disease Genetic VariantsdiseaseAlzheimer's Diseasedisease

Protocol

Human brain tissue: Postmortem samples from (1) Cognitively normal young adults (20-40 years, n=10). (2) Cognitively normal aged (70-90 years, n=10). (3) AD patients (Braak V-VI, n=10). (4) PD patients (Braak α-syn stage 4-6, n=10). Regions: Frontal cortex (Brodmann area 9), hippocampus (CA1), substantia nigra (for PD). Sectioning: 40 μm free-floating sections, every 10th section. Immunohistochemistry: IBA1 (pan-microglial marker, 1:500, Wako), CD68 (phagocytic marker, 1:200), HLA-DR (activation marker, 1:100). DAB or fluorescence detection. Morphological classification: (1) Ramified: >3 primary processes, extensive branching, small soma (<10 μm). (2) Amoeboid: 0-1 process, large soma (>15 μm), rounded. (3) Phagocytic: CD68+ inclusions, enlarged soma, retracted processes.

...

Expected Outcomes

Quantitative predictions: (1) Young adults: 85-90% ramified microglia, 5-8% amoeboid, 3-5% phagocytic, <2% dystrophic. Sholl: peak intersections 8-12 at 20 μm radius. (2) Aged normal: 60-70% ramified, 10-15% amoeboid, 8-12% phagocytic, 10-15% dystrophic. Sholl: peak decreases to 5-8, shifted to 15 μm (less branching, shorter processes). (3) AD cases: 40-50% ramified, 20-25% amoeboid (activated), 15-20% phagocytic (plaques), 15-20% dystrophic. Hippocampus more affected than cortex.

...

Success Criteria

Primary: Significant difference in microglial morphology distribution across groups (chi-square test, p<0.001). Aged/diseased brains show >2-fold increase in dystrophic microglia vs. young adults (p<0.01, Dunn post-hoc). Secondary: (1) Ramified microglia decrease with age/disease (linear trend, p<0.01). (2) Sholl analysis: peak intersections and process length decrease with age (p<0.01, mixed-effects model). (3) Dystrophic microglia: >60% express p16INK4a (senescence marker, p<0.001 vs. ramified).

...

Related Hypotheses (0)

No related hypotheses

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.